Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Research Reporting and Publication Support

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

541830 - Media Buying AgenciesView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Nida
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Prepare technical summaries, conference abstracts, and support manuscript development for peer-reviewed journals based on study findings, in coordination with NIDA IRP and partner institutions.

Similar Contracts

Same NAICS industry code

NAICS: 541830
New
SLED
Media Buying and Creative Support IDIQThe Port of Seattle, through its External Relations division, is issuing an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for comprehensive media buying and creative support services under solicitation number 00322873, with a NAICS code of 541830. The contract, valued at up to $2 million over a five-year ordering period, will engage a professional firm to deliver creative development, sponsorship management, and paid media purchasing aligned with the Port’s budget, target audience, and strategic goals. The Consultant will collaborate closely with Port marketing leaders to interpret creative briefs, develop compelling advertising content and copy, negotiate favorable media rates, execute media buys, manage ad insertion, and deliver detailed post-campaign analytics. Work will be ordered through Service Directives and must be performed in accordance with strict quality control measures, requiring final creative and budget approvals from Port personnel before any deployment. The firm must provide fully burdened hourly rates for key personnel—including account managers, project managers, creative directors, designers, copywriters, media buyers, analysts, and strategists—alongside a fixed fee percentage of advertising spend and a clear breakdown of other direct costs. The contract includes a three-year base term with an option for two additional years, and performance will be extended as needed to complete work initiated during the ordering period. Compliance with a wide range of legal, ethical, and operational standards is mandatory, including adherence to non-discrimination laws, federal and state regulations, the Port’s Values and Standards, and its Proclamation against Russian Federation-based entities. The Consultant must maintain rigorous confidentiality, indemnify the Port for liability arising from their services, and carry specialized insurance coverage where applicable, such as for cyber, pollution, liquor, or special event risks. Subcontracting is permitted but only after Port review and approval of both the subconsultant and their billing rates, and all subconsultants must assume obligations under the Agreement except for insurance requirements. The Consultant is required to report monthly payments to subconsultants—including their classification as Minority, Women, Disadvantaged, Veteran, or LGBTQ-owned businesses—via the Port’s Contractor Database System. All invoices must be submitted monthly with a clear reference to the Agreement number, identify retail sales tax as a separate line item, and adhere to Net 30 payment terms. Proposals must be submitted electronically by August 4, 2026, in searchable PDF format not exceeding six pages, with required exhibits submitted as separate Excel and Word files, excluding
External Relations

POSTED

1 day ago

DEADLINE

in 11 days
View Details
NAICS: 541830
New
Federal
Content Development for Evidence-Based Therapy ModulesThe contract seeks the development and periodic updates of digital therapy content modules that reflect the latest evidence-based practices in physical and occupational therapy, specifically tailored to meet military healthcare standards. The work will focus on creating clinically accurate, scalable, and accessible digital resources to support service members' rehabilitation needs, with content designed to align with the operational and medical protocols used within Department of Defense healthcare systems. The deliverables must incorporate current research, best practices, and feedback from clinical providers to ensure relevance and effectiveness in real-world military medical environments. The opportunity is issued as a subcontract under the Defense Health Agency Hcd West, with performance expected to take place at Camp Pendleton, California, 92055. The NAICS code 541830 identifies this as a professional, scientific, and technical services contract related to advertising, marketing, and related services, though the scope is strictly therapeutic content creation. Proposals must be submitted by July 27, 2026, and the solicitation was posted on July 22, 2026. No set-aside designation is specified, and the contract is open to eligible subcontractors capable of delivering high-quality, compliant digital therapy materials that meet federal and military healthcare requirements.
Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541690
New
Federal
Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIVThis solicitation, numbered 75N95026R0007, seeks a commercial services provider to conduct a pharmacoepidemiological study evaluating the impact of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on HIV-related outcomes and alcohol and substance use disorders in adults living with HIV, using electronic health record data from the Department of Veterans Affairs. The research will employ propensity-score matching and multivariable linear regression to assess changes in health outcomes before and after GLP-1RA exposure, with findings intended to inform future clinical trials. The contract is structured as a firm-fixed-price purchase order with a one-year base period from August 7, 2026, through August 6, 2027, and includes three optional one-year extensions through August 6, 2030. The scope of work requires the contractor to manage and analyze de-identified VA data under strict security protocols, with no personally identifiable information permitted to leave VA systems, and to support the development of conference abstracts and peer-reviewed publications led by NIDA and its collaborators. All deliverables must consist of aggregate-level results only, ensuring compliance with federal data privacy requirements. The solicitation is full and open with no set-aside, classified under NAICS code 541690 with a small business size standard of $19 million in annual receipts. Proposals must include a technical submission demonstrating capability to perform the research, a detailed price proposal with labor categories, estimated hours, fully loaded rates, and other direct cost breakdowns, and must be submitted electronically by 9:00 a.m. EST on July 30, 2026, to Robin.Knightly@nih.gov. All offerors must maintain active registration in SAM, provide their UEI and TIN, and certify compliance with multiple FAR provisions governing ethics, whistleblower protections, equal opportunity, labor standards, cybersecurity, trafficking in persons, and prohibitions on internal confidentiality agreements. Technical capability and past performance are significantly more important than price in the evaluation, with award going to the most advantageous offer based on overall value. The contract incorporates numerous FAR clauses addressing subcontracting, payment by electronic funds transfer, service contract labor standards, and data security, and requires strict adherence to VA data handling protocols and federal compliance standards. No physical delivery or packaging requirements are specified, and the place of performance is Bethesda, Maryland.
Other Scientific and Technical Consulting Services

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 541990
Federal
Notice of Ordering Period Extension-Clinical Evaluation of Phenserine Tartrate Extended Controlled Release TabletThe National Institute on Aging intends to extend the ordering period of its existing IDIQ contract with the University of Exeter, UK, by one year, moving the deadline from August 1, 2026, to August 1, 2027, to ensure completion of planned clinical work under Task Orders 2 and 3. This contract supports the clinical evaluation of (-)-Phenserine tartrate Extended Controlled Release Tablet (ECRT) in two patient populations: individuals with early mild Alzheimer’s disease and those with mild to moderate traumatic brain injury. The study involves phase 1/2 clinical trials to assess pharmacokinetic and pharmacodynamic profiles, including steady-state drug concentrations, target engagement, tolerability, and biomarker outcomes through blood sampling, cognitive testing, and brain imaging. The contractor will deliver all necessary personnel, facilities, and resources to administer the drug under rigorously controlled conditions, with the government providing the drug substance, including an immediate-release formulation if needed to achieve target plasma levels. The work is non-competitive, authorized under 41 U.S.C. 3304(a)(1) and aligned with RFO Subpart 6.103-1, as the University of Exeter is the only responsible source capable of delivering the required expertise. The contract is classified under NAICS code 541990 with a $19.5 million size standard, and no follow-on procurements are anticipated. All responses to this presolicitation notice must be submitted electronically by July 30, 2026, to the designated contracting officer, and require an active SAM registration, UEI, TIN, and business size certification.
All Other Professional, Scientific, and Technical Services

POSTED

9 days ago

DEADLINE

in 6 days
View Details